Jefferies Reiterated Buy on Edwards Lifesciences (EW) after Surveys Show Favorable Results
Tweet
Share
E-mailGet Alerts EW Hot Sheet
Price: $91.60 -1.04%
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Jefferies reiterated a Buy rating on Edwards Lifesciences (NYSE: EW) and increased its price target to $125.00 (from $115.00).
“We published two physician surveys on transcatheter aortic valve replacement (TAVR), one of early adopters and the other of current non-users,” said analyst Raj Denhoy.“Based on the results, which show strong and sustainable procedure growth, we are increasing our forecasts and target.”
Overall, the survey showed very good growth trends for Sapien.
“Among current users, procedure growth is expected to be very strong and among non-users, a vast majority expects to adopt the technology over the next two years. The implications on the near-term outlook for EW are likewise very favorable,” said Denhoy
For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $105.52 yesterday.
“We published two physician surveys on transcatheter aortic valve replacement (TAVR), one of early adopters and the other of current non-users,” said analyst Raj Denhoy.“Based on the results, which show strong and sustainable procedure growth, we are increasing our forecasts and target.”
Overall, the survey showed very good growth trends for Sapien.
“Among current users, procedure growth is expected to be very strong and among non-users, a vast majority expects to adopt the technology over the next two years. The implications on the near-term outlook for EW are likewise very favorable,” said Denhoy
For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $105.52 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Freedom Broker Upgrades Serve Robotics (SERV) to Buy
- Honasa Consumer Ltd (HONASA:IN) PT Raised to INR720 at ICICI Securities
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Analyst PT ChangeRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
